Cite
HARVARD Citation
Askling, J. et al. (2009). Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register. Annals of the rheumatic diseases. 68 (5), pp. 648-653. [Online].